There's a company in San Diego called Azco Biotech acting as sales representative for Dover. I've read that the Broad has one, although they say that it's not in use for production sequencing. Is this well-intended system still commercially viable? Does anyone want one? It would seem that technology has moved on (e.g., Ion Torrent).
-
-
Rubenken: Thanks for posting. The Polonator is still commercially available, but despite its low upfront and recurring cost, its throughput has lagged behind that of the two major players. That said, we have not been idle, but have had our heads down working to substantially increase its performance. We will shortly be providing an update on our progress, but I expect that we will do that via Julia Karow of In Sequence. Stay tuned.
Kevin
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment